InVivo Therapeutics will be exhibiting at the 2014 Congress of Neurological Surgeons (CNS) annual meeting, which will be held in Boston (USA) on 18–22 October. The exhibit, InVivo’s first at a major medical conference, will focus on strengthening and expanding the company’s neurosurgical network and increasing awareness about its ongoing clinical pilot study of its Neuro-Spinal Scaffold to treat acute spinal cord injury.
A press release reports that the company will also host a social event in conjunction with the Congress, which is estimated to draw more than 3,000 attendees this year.
Mark Perrin, InVivo’s CEO, says, “The CNS annual conference is one of the premier meetings in the world for neurosurgeons. We are delighted to be exhibiting this year, not only because the Congress anticipates this will be one of the largest CNS gatherings in history, but because we look forward to connecting with our medical colleagues in the neurosurgical community to discuss our cutting-edge technology, and—more importantly—how this technology might forever change the lives of spinal cord injury patients.”
